Gender differences in the response to sertraline versus imipramine in non-melancholic depression

Baca, Enrique; Porras-Chavarino, A.

doi:10.1016/s0924-977x(00)80229-1

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…100 Although there appears to be no difference in depression symptom severity, generally women respond better to SSRIs 101 than men, who, conversely, respond better to TCAs. [102][103][104][105][106] This may due to the fact that women produce more tryptophan and less cortisol when exposed to SSRIs. 107 Interestingly, in two studies carried out by our research group, we noted better response of compulsive symptoms to either fluvoxamine or clomipramine in men than in women who suffer from obsessivecompulsive disorder.…”

Section: Antipsychoticsmentioning

confidence: 99%

Pharmacokinetics and pharmacodinamics of psychotropic drugs: effect of sex

et al. 2013

View full text Add to dashboard Cite

Data on the specific effects of sex on pharmacokinetics, as well as tolerability, safety, and efficacy of psychotropic medications are still meager, mainly because only recently sex-related issues have attracted a certain degree of interest within the pharmacological domain. Therefore, with the present study, we aimed to provide a comprehensive review of the literature on this topic, through careful MEDLINE and PubMed searches of the years 1990-2012. Generally, data on pharmacokinetics are more consistent and numerous than those on pharmacodynamics. Sex-related differences have been reported for several parameters that influence pharmacokinetics, such as gastric acidity, intestinal motility, body weight and composition, blood volume, liver enzymes (mainly the cytochrome P450), or renal excretion, which may alter plasma drug levels. Sex-related peculiarities may also account for a different sensitivity of men and women to side effects and toxicity of psychotropic drugs. Further, some differences in drug response, mainly to antipsychotics and antidepressants, have been described. Further studies are, however, necessary to explore more thoroughly the impact of sex on the pharmacokinetics and pharmacodynamics of psychotropic drugs, in order to reach the most appropriate and tailored prescription for each patient.

show abstract